SCTX · Scribe Therapeutics Inc. Common Stock
View on chartInsiders & Stakes
| Aghazadeh Behzad Director | ▲ Buy | Open Market | 3,088,888 Shares held | 7/28/2026 | View profile |
| AH Bio Fund II, L.P. | ▲ Buy | Open Market | 2,385,075 Shares held | 7/27/2026 | View profile |
| ORBIMED ADVISORS LLC 10% Owner | ▲ Buy | Open Market | 1,348,825 Shares held | 7/27/2026 | View profile |
| Carl L. Gordon Director | ▲ Buy | Open Market | 1,348,825 Shares held | 7/27/2026 | View profile |
| Jennifer A. Doudna | ▼ Sell | Other | 603,547 Shares held | 7/27/2026 | View profile |
| Svetlana Lucas Director | ▲ Buy | Open Market | 3,000 Shares held | 7/23/2026 | View profile |
| Parrot David Chief Financial Officer | ▲ Buy | Open Market | 1,333 Shares held | 7/23/2026 | View profile |
Transaction History
| Aghazadeh Behzad | ▲ Buy | Open Market | 7,905 | $144K | 7/28/2026 |
| AH Bio Fund II, L.P. | ▼ Sell | Other | 2,051,742 | — | 7/27/2026 |
| AH Bio Fund II, L.P. | ▼ Sell | Other | 697,650 | — | 7/27/2026 |
| AH Bio Fund II, L.P. | ▲ Buy | Open Market | 333,333 | $5.0M | 7/27/2026 |
| Carl L. Gordon | ▼ Sell | Other | 348,825 | — | 7/27/2026 |
| Carl L. Gordon | ▲ Buy | Open Market | 1,000,000 | $15.0M | 7/27/2026 |
| ORBIMED ADVISORS LLC | ▼ Sell | Other | 348,825 | — | 7/27/2026 |
| ORBIMED ADVISORS LLC | ▲ Buy | Open Market | 1,000,000 | $15.0M | 7/27/2026 |
| Jennifer A. Doudna | ▼ Sell | Other | 12,511 | — | 7/27/2026 |
| Aghazadeh Behzad | ▲ Buy | Open Market | 2,333,333 | $35.0M | 7/24/2026 |
| Aghazadeh Behzad | ▲ Buy | Open Market | 50,000 | $1.1M | 7/24/2026 |
| Svetlana Lucas | ▲ Buy | Open Market | 3,000 | $45K | 7/23/2026 |
| Parrot David | ▲ Buy | Open Market | 1,333 | $20K | 7/23/2026 |
| Parrot David | ▲ Buy | Open Market | 1,333 | $20K | 7/23/2026 |